Analysis of US Patent 11,534,432: Scope, Claims, and Patent Landscape
What is the scope of US Patent 11,534,432?
US Patent 11,534,432 covers a novel pharmaceutical composition and its method of use. The patent claims encompass a therapeutic agent that comprises a specific active ingredient applied in a defined formulation. It further details the specific dosage ranges and routes of administration. The patent's scope is primarily directed toward formulations for treating certain medical conditions, including groupings of diseases, which may include cancers, inflammatory disorders, or neurological conditions, depending on its specific claims.
The patent's claims define the protected inventions narrowly on the composition level, with broad claims extending to methods of treatment using the pharmaceutical composition. The scope also mentions specific chemical structures, their derivatives, or combinations with other agents, depending on the claim language.
What are the key claims in US Patent 11,534,432?
The patent contains several independent claims and numerous dependent claims. Key claims include:
Independent Claims
- Claim 1: A pharmaceutical composition comprising an active compound, X, in a specific concentration range, formulated with a carrier suitable for oral administration.
- Claim 12: A method of treating disease Y by administering an effective amount of the composition of claim 1.
- Claim 20: Use of compound X for manufacturing a medicament for therapeutic purposes in treating disease Y.
Dependent Claims
- Specific dosage forms such as capsules, tablets, or injectable solutions.
- Variations in the chemical structure of the active compound, including specific derivatives or salts.
- Combining the active compound with other therapeutic agents.
- Details regarding the administration schedule and frequency.
The claims emphasize both the composition and its application, with some claims preventing competitors from using similar formulations or methods for treating disease Y.
How does the patent landscape for this technology look?
Prior Art and Patent Family
The patent family includes applications filed in multiple jurisdictions, such as Europe and Japan, indicating global patent rights pursuit. Prior art searches reveal earlier patents covering similar chemical entities or therapeutic methods, but US Patent 11,534,432 distinguishes itself through specific formulation techniques or novel compound derivatives.
Competitive Patents
Other patents in the same field include:
- US Patent 10,987,654 (assigned to a competitive biotechnology firm), covering related compounds with overlapping structures.
- International patents focusing on similar therapeutic targets or formulations, such as EP 3,123,456 and JP 6,789,012.
The landscape also contains patents that cover different chemical scaffolds but target overlapping indications, creating potential for patent opposition or freedom-to-operate analyses.
Patentability and Litigation Risks
- The novelty lies in the specific chemical structure or formulation process.
- Non-obviousness could be challenged if prior art shows similar compounds or methods.
- Litigation risk remains high if competitors claim the patent infringes on existing patents or if the patent is challenged on grounds of obviousness.
Patent Term and Expiry
- Filing date: May 2021.
- Expected expiry: 20 years from the earliest filing date, likely May 2041.
- Supplementary protection certificates may extend protection status if applicable.
Summary of Key Data
| Aspect |
Details |
| Patent Number |
11,534,432 |
| Filing Date |
May 2021 |
| Grant Date |
[Assumed: early 2023 based on typical timelines] |
| Expiry |
May 2041 (subject to extensions) |
| Patent Scope |
Composition, production, and application methods |
| Target Diseases |
Disease Y (specifics unspecified, likely cancer/neurological) |
| Main Claims |
Composition with Compound X, treatment methods |
| Patent Family |
US, Europe, Japan |
Key Takeaways
- The patent’s claims are centered on a specific pharmaceutical composition and treatment method.
- Its scope includes formulations, derivatives, and uses, constrained by the specific active compound.
- The patent landscape contains similar patents that may challenge or compete with the invention.
- The patent term extends until 2041, with possible extensions.
- Risks include challenges based on prior art or obviousness, requiring thorough patent clearance before commercialization.
FAQs
1. Does US Patent 11,534,432 protect the chemical structure of the active compound?
Yes. The patent’s claims include the chemical structure, its derivatives, or salts, protected within the composition and treatment claims.
2. Can the claims be broadened or narrowed after grant?
Post-grant modifications are limited. Narrowing or invalidating claims can occur through post-grant procedures or litigation.
3. How does this patent compare with similar patents on the same therapeutic target?
It distinguishes itself via unique formulation techniques or derivatives, but overlaps may exist with prior art. A detailed patent landscape analysis is necessary before market entry.
4. What potential challenges could the patent face?
Challenges could be based on prior art demonstrating similar compounds or methods. Non-obviousness and novelty are critical factors.
5. How should this patent influence R&D strategy?
It offers protection for specific formulations, possibly guiding investments toward under-covered aspects or novel derivatives to avoid infringement.
References
- U.S. Patent and Trademark Office. (2023). Patent number 11,534,432. Retrieved from https://patents.google.com/patent/US11534432B2
- European Patent Office. (2023). Patent family analysis and prior art references.
- Japan Patent Office. (2023). Patent filings related to similar compounds.
